Aquestive Therapeutics, Inc. (AQST)
NASDAQ: AQST · Real-Time Price · USD
4.090
-0.010 (-0.24%)
At close: Apr 28, 2026, 4:00 PM EDT
4.090
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:10 PM EDT
Aquestive Therapeutics Employees
Aquestive Therapeutics had 147 employees as of December 31, 2025. The number of employees increased by 5 or 3.52% compared to the previous year.
Employees
147
Change (1Y)
5
Growth (1Y)
3.52%
Revenue / Employee
$303,027
Profits / Employee
-$569,959
Market Cap
499.16M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Tilray Brands | 2,842 |
| Canopy Growth | 960 |
| Emergent BioSolutions | 900 |
| Kamada | 462 |
| Evolus | 334 |
| Esperion Therapeutics | 294 |
| Akebia Therapeutics | 194 |
| Ironwood Pharmaceuticals | 100 |
AQST News
- 6 days ago - Bragar Eagel & Squire, P.C. Reminds Aquestive Therapeutics, Inc. Investors They Have Until May 4th to Seek Lead Plaintiff Role - GlobeNewsWire
- 12 days ago - AQST Lawsuit Alleges Allegedly Concealed Anaphylm NDA Deficiencies - AQUESTIVE THERAPEUTICS, INC. Investors Face Losses Following Allegedly Concealed Anaphylm NDA Deficiencies: SueWallSt - PRNewsWire
- 19 days ago - AQUESTIVE THERAPEUTICS, INC. (AQST) DEADLINE ALERT Bernstein Liebhard LLP Reminds Aquestive Therapeutics, Inc. Investors of Upcoming Deadline - GlobeNewsWire
- 5 weeks ago - Aquestive Therapeutics Announces New Role of Lori J. Braender and Appointment of Thomas A. - GlobeNewsWire
- 6 weeks ago - AQST Lawsuit Alleges Analyst Slashed Price Target - AQUESTIVE THERAPEUTICS, INC. Investors Face Losses Following Analyst Slashed Price Target: SueWallSt - PRNewsWire
- 7 weeks ago - Aquestive Therapeutics Transcript: The Citizens Life Sciences Conference 2026 - Transcripts
- 7 weeks ago - Aquestive Therapeutics Announces Grant of Inducement Award Pursuant to Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 7 weeks ago - Aquestive Therapeutics Transcript: Leerink Global Healthcare Conference 2026 - Transcripts